Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

GE HealthCare Technologies (GEHC) Shares Repurchased (2025 - 2026)

GE HealthCare Technologies filings provide 2 years of Shares Repurchased readings, the most recent being $100.0 million for Q1 2026.

On a quarterly basis, Shares Repurchased changed N/A to $100.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $300.0 million, a N/A change, with the full-year FY2025 number at $200.0 million, changed N/A from a year prior.
Shares Repurchased hit $100.0 million in Q1 2026 for GE HealthCare Technologies, roughly flat from $100.0 million in the prior quarter.
In the past five years, Shares Repurchased ranged from a high of $100.0 million in Q2 2025 to a low of $100.0 million in Q2 2025.